Texas A&M University LibrariesTexas A&M University LibrariesTexas A&M University Libraries
    • Help
    • Login
    OAKTrust
    View Item 
    •   OAKTrust Home
    • University Libraries
    • Business Library and Collaboration Commons
    • Texas A&M University Patents
    • View Item
    •   OAKTrust Home
    • University Libraries
    • Business Library and Collaboration Commons
    • Texas A&M University Patents
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Treatment of neoplastic disease with oral interferon

    Thumbnail
    View/ Open
    5824300.pdf (1.001Mb)
    Date
    1998-10-20
    Author
    Cummins, Joseph M.
    Metadata
    Show full item record
    Abstract
    Neoplastic diseases are treated by the administration of human interferon, particularly IFN-α, at a dosage of from about 0.01 to about 5 IU/lb./day such that the interferon is held in contact with the patient's oral and pharyngeal mucosae. The interferon is administered in a solid dosage from, e.g., a saliva-dissolvable lozenge.
    URI
    https://hdl.handle.net/1969.1/176595
    Subject
    424/85.7
    424/85.4
    424/85.6
    424/464
    A61K 38/21
    A61K 38/212
    Y10S 435/811
    Collections
    • Texas A&M University Patents
    Citation
    Cummins, Joseph M. (1998). Treatment of neoplastic disease with oral interferon. United States. Patent and Trademark Office; Texas A&M University. Libraries. Available electronically from https : / /hdl .handle .net /1969 .1 /176595.

    DSpace software copyright © 2002-2016  DuraSpace
    Contact Us | Send Feedback
    Theme by 
    Atmire NV
     

     

    Advanced Search

    Browse

    All of OAKTrustCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsDepartmentTypeThis CollectionBy Issue DateAuthorsTitlesSubjectsDepartmentType

    My Account

    LoginRegister

    Statistics

    View Usage Statistics
    Help and Documentation

    DSpace software copyright © 2002-2016  DuraSpace
    Contact Us | Send Feedback
    Theme by 
    Atmire NV